CD133 Expression at the Metastatic Site Predicts Patients’ Outcome in Colorectal Cancer with Synchronous Liver Metastasis

[1]  W. Scheithauer,et al.  Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Y. Sakamoto,et al.  Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival , 2014, Annals of Surgical Oncology.

[3]  I. Endo,et al.  Patients with CD133-Negative Colorectal Liver Metastasis Have a Poor Prognosis After Hepatectomy , 2014, Annals of Surgical Oncology.

[4]  G. Fürst,et al.  HGF and SDF‐1‐mediated mobilization of CD133+BMSC for hepatic regeneration following extensive liver resection , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[5]  Jun Liang,et al.  Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma , 2013, Oncology letters.

[6]  Zhonghua Zhao,et al.  Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential. , 2013, Gastroenterology.

[7]  H. Olsson,et al.  Population‐based data from the Swedish Colon Cancer Registry , 2013, The British journal of surgery.

[8]  Shicai Chen,et al.  CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis , 2013, PloS one.

[9]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[10]  Jian Huang,et al.  Prognostic role of CD133 expression in colorectal cancer: a meta-analysis , 2012, BMC Cancer.

[11]  H. Nagawa,et al.  CD133(-) cells, derived from a single human colon cancer cell line, are more resistant to 5-fluorouracil (FU) than CD133(+) cells, dependent on the β1-integrin signaling. , 2012, The Journal of surgical research.

[12]  H. Nagawa,et al.  Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer , 2012, Medical Oncology.

[13]  Serge Battu,et al.  Cancer stem cell sorting from colorectal cancer cell lines by sedimentation field flow fractionation. , 2012, Analytical chemistry.

[14]  P. Cejas,et al.  Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[15]  F. Qiu,et al.  Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells. , 2010, Carcinogenesis.

[16]  L. Terracciano,et al.  Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer , 2010, British Journal of Cancer.

[17]  E. Van Cutsem,et al.  Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. , 2009, The New England journal of medicine.

[18]  J. McCall,et al.  Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases , 2009, The British journal of surgery.

[19]  D. Choi,et al.  Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. , 2009, World journal of gastroenterology.

[20]  Tao Zhang,et al.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. , 2009, Cancer research.

[21]  Lei Du,et al.  CD44 is of Functional Importance for Colorectal Cancer Stem Cells , 2008, Clinical Cancer Research.

[22]  M. Todaro,et al.  Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.

[23]  M. Biffoni,et al.  Identification and expansion of the tumorigenic lung cancer stem cell population , 2008, Cell Death and Differentiation.

[24]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[25]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[26]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[27]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[28]  G. Launoy,et al.  A population‐based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer , 2006, The British journal of surgery.

[29]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[30]  A. Viera,et al.  Understanding interobserver agreement: the kappa statistic. , 2005, Family medicine.

[31]  J. Itskovitz‐Eldor,et al.  CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia. , 2005, Stem cells.

[32]  F. Lévi,et al.  Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? , 2004, Annals of surgery.

[33]  G. Maddern,et al.  The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. , 2004, Archives of surgery.

[34]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[35]  長田 寛之.  Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer , 2012 .

[36]  前田 真一.  CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer , 2008 .

[37]  Richard Stang,et al.  Resection of colorectal liver metastases , 1997, Journal of Gastrointestinal Surgery.

[38]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .